Form 4/A for IRD: 30,350 shares withheld for RSU taxes, no sale

Rhea-AI Filing Summary

Opus Genetics, Inc. (IRD) reported an insider transaction amendment. The Chief Executive Officer and Director filed a Form 4/A clarifying that 30,350 shares of common stock were withheld by the issuer on 11/01/2025 to satisfy tax obligations from an RSU vesting event, coded F (tax withholding). This was not an open‑market sale.

Following the transaction, the reporting person beneficially owned 1,291,654 shares directly. The amendment was filed solely to add a footnote explaining the nature of the transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Magrath George

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	30,350	$2.30	$70K

Holdings After Transaction: Common Stock — 1,291,654 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Magrath George

(Last) (First) (Middle)

C/O OPUS GENETICS, INC.

8 DAVIS DRIVE, SUITE 220

(Street)

DURHAM NC 27713

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Opus Genetics, Inc. [ IRD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
11/04/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/01/2025		F(1)		30,350	D	$2.3	1,291,654	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities.

Remarks:

This amendment to the Form 4 the Reporting Person filed on November 4, 2025, is being filed solely to add a footnote disclosing that the reported transaction was not an open market sale of securities.

	/s/ Amy Rabourn, by Power of Attorney	11/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Opus Genetics (IRD) disclose in this Form 4/A?

An amendment stating the issuer withheld 30,350 shares on 11/01/2025 to cover RSU tax withholding; it was not an open‑market sale.

Who is the reporting person and their role at IRD?

The reporting person is the company’s Chief Executive Officer and a Director.

What does transaction code F indicate here?

Code F indicates shares were withheld to satisfy tax withholding on an equity award vesting.

How many shares does the insider own after the transaction?

Beneficial ownership after the transaction is 1,291,654 shares, held directly.

What was the price shown for the withheld shares?

The price column lists $2.3 per share for the withheld shares.

Why was this Form 4 amended?

It was amended to add a footnote clarifying the transaction was not an open‑market sale.